Aurora Cannabis, Inc. (NYSE: ACB) reported a wider loss for the fourth quarter of 2020, hurt by a 5% decrease in revenues. The company’s stock fell sharply during Tuesday’s after-hours trading session soon after the announcement.
The Canada-based medical marijuana company said its loss from continuing operations widened to C$1.86 billion in the fourth quarter from C$136.13 million in the third quarter. The deterioration in the bottom-line performance reflects a 5% decrease in revenues to C$72.1 million.
Shares of Aurora Cannabis closed Tuesday’s regular session higher in the New York Stock Exchange but decreased during the extended trading session. The stock, which has been on a losing streak for several months, has lost about 70% so far this year.
Most Popular
SNAP Earnings: All you need to know about Snap’s Q2 2021 earnings results
Snap Inc. (NYSE: SNAP) reported second quarter 2021 earnings results today. Revenues increased 116% year-over-year to $982 million. Net loss amounted to $151.6 million, or $0.10 per share, compared to
TWTR Earnings: Twitter swings to profit in Q2 as revenues surge 74%; results beat
Microblogging platform Twitter, Inc. (NYSE: TWTR) Thursday reported a profit for the second quarter of fiscal 2021, compared to a loss last year. Both earnings and revenue came in above
Earnings Infographic: Intel (INTC) Q2 2021 profit, revenue beat estimates
Intel Corporation (NASDAQ: INTC) Thursday reported financial results for the second quarter of 2021. The revenue was reported at $19.6 billion compared to $19.7 billion in the previous year's second
